Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
27,995,500
-
Number of holders
-
66
-
Total 13F shares, excl. options
-
31,644,913
-
Shares change
-
+11,106,400
-
Total reported value, excl. options
-
$291,721,875
-
Value change
-
+$102,579,332
-
Number of buys
-
49
-
Number of sells
-
21
-
Price
-
$9.26
Institutional Holders of Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (SYRS) as of Q2 2019
As of 30 Jun 2019 Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (SYRS) had 66 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 31,644,913 shares of stock of the company.
Largest 10 holders included FMR LLC, ARK Investment Management LLC, Redmile Group, LLC, Nikko Asset Management Americas, Inc., BlackRock Inc., VANGUARD GROUP INC, Samsara BioCapital, LLC, Sumitomo Mitsui Trust Holdings, Inc., DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), and BAKER BROS. ADVISORS LP.
This table shows 66 institutional shareholders of the security as of 30 Jun 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.